Showing results (141-150 of 335) with videos related to

Sort By:
Pageof 34
Cancer Medicine|November 8, 2023
The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in ChinaJinjun Yang, Lei Zhao, Yu Wu, et al.
Clinical and Experimental Medicine|September 9, 2024
Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody eraYan Li, Xinyi Zhang, Zhongqing Zou, et al.
Cell Reports. Medicine|May 1, 2026
Cross-tissue atlas of mucosa-associated lymphoid tissue lymphomas reveals intratumoral heterogeneity and microenvironmental subtypesKai Kang, Yijun Wu, Xu Sun, et al.
Frontiers in Immunology|April 28, 2022
Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 PatientsAilin Zhao, Jinrong Yang, Meng Li, et al.
International Immunopharmacology|January 25, 2025
Bortezomib enhances the efficacy of BCMA CAR-T therapy through up-regulating BCMA expression in myeloma cellsJiaqian Li, Rongbing Guo, Dan Li, et al.
Experimental and Therapeutic Medicine|August 9, 2020
Trp53 regulates platelets in bone marrow via the PI3K pathwayMingming Yang, Qing Liu, Ting Niu, et al.
The Neurologist|November 14, 2015
Differential Lesion Patterns on T2WI and FLAIR Sequences in Cryptogenic Stroke Patients With Patent Foramen OvaleYang-Yang Huang, Bei Shao, Xian-Da Ni, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|December 3, 2009
[Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients]Xiao-Yan Mu, Hong Chang, Ting Liu, et al.
Frontiers in Immunology|April 29, 2025
Integration of anti-PD-1 antibody into chemotherapeutic regimens improved the outcome of aggressive NK cell leukemia: a single-center retrospective real-world analysisKai Shen, Yi Liao, Yang Dai, et al.
European Journal of Medicinal Chemistry|March 5, 2026
Discovery of 2-(methylamino)-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidine derivatives as novel HsClpP activators for multiple myeloma therapyXiang Liu, Jinglong Gu, Yan Liu, et al.
Pageof 34